Arbutus Biopharma (ABUS) Tax Provisions (2015 - 2022)

Arbutus Biopharma (ABUS) posted Tax Provisions of $4.4 million for Q1 2022, up 135.11% sequentially from -$12.7 million in Q3 2019.

Arbutus Biopharma (ABUS) Tax Provisions (2015 - 2022) Analysis & Trends

Arbutus Biopharma has reported Tax Provisions for 6 years, with the latest figure at $4.4 million in Q1 2022.

Quarterly Tax Provisions changed N/A year-over-year to $4.4 million in Q1 2022, while the trailing twelve-month figure through Dec 2022 was $4.4 million (changed N/A YoY) and the FY2022 annual result came in at $4.4 million, changed N/A from the prior year.
Tax Provisions grew to $4.4 million in Q1 2022 per ABUS's latest filing, from -$12.7 million in the prior quarter.
Over five years, Tax Provisions peaked at $4.4 million in Q1 2022 and troughed at -$12.7 million in Q3 2019.
A 3-year average of -$4.2 million and a median of -$4.3 million in 2018 frame the typical range for Tax Provisions.
The widest YoY moves for Tax Provisions: up 195.56% in 2019, down 195.56% in 2019.
Over 3 years, Tax Provisions stood at -$4.3 million in 2018, then sank by 195.56% to -$12.7 million in 2019, then soared by 135.11% to $4.4 million in 2022.
According to Business Quant data, Tax Provisions over the past three periods registered $4.4 million, -$12.7 million, and -$4.3 million for Q1 2022, Q3 2019, and Q3 2018 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	59.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	75.45 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	267.73
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	13.31 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	1.90 Mn
10	Arbutus Biopharma	922.95 Mn	830.33 Mn	-	-

Download Data